Related by context. Frequent words. (Click for all words.) 75 Receives Orphan Drug Designation 74 Aloxi R 71 Release Tablets 71 Initiates Phase II 70 ABILIFY R 70 Completes Enrollment 70 Generic Version 70 Drug Candidate 69 FDA Accepts 69 Phase III Clinical Trial 69 Pivotal Phase III 69 Kuvan R 69 Announces FDA Clearance 69 Single Dose 69 Patient Enrollment 69 Phase III Trial 68 THALOMID 68 Pivotal Study 68 AMRIX 68 LIVALO 68 Clinical Trial Results 68 Extended Release Tablets 67 Rebif ® 67 Transcept Pharmaceuticals 67 Testim R 67 BioGlue R 67 FDA Clears 67 Presents Positive 67 Recombinant Human 67 Frova R 66 Lubiprostone 66 Nexavar ® 66 Significantly Improves 66 Pivotal Trial 66 Significantly Reduces 66 Panzem R 66 Ixempra 66 Receives FDA Clearance 66 Eloxatin ® 65 Entereg R 65 Inc Therapeutic Competitors 65 Patent Covering 65 Preclinical Data 65 Alferon N Injection 65 Loramyc R 65 TYGACIL 65 Delayed Release 65 DRRX 65 Pivotal Phase 65 Commences Phase 65 injection USP 65 Positive Opinion 64 Vfend 64 Valsartan 64 Icatibant 64 Alinia 64 OPANA ER 64 Exploit collaboration 64 Angiox 64 ONTAK 64 Oral Solution 64 Octreotide 64 Azilect ® 64 Initiates Phase 64 Monoclonal Antibody 64 Study Demonstrates 64 SANCTURA R 64 ZALBIN 64 Surgical Adhesive 64 PLAVIX R 64 Initiate Phase 64 PROVIGIL 64 Clofarabine 64 #mg #mg [002] 64 Eligard R 64 R bortezomib 64 AMITIZA R 64 Ventavis 64 Cetrorelix 64 ACTIQ 64 CRTX 64 Gemzar ® 64 REVLIMID R 64 SANOFI AVENTIS 63 Extended Release 63 NEBIDO R 63 TELINTRA 63 ARCOXIA 63 Pulmonary Arterial Hypertension 63 Milnacipran 63 Actimmune R 63 Nasal Spray 63 FDA Approves 63 Onalta 63 Chronic Hepatitis B 63 Diabetic Neuropathy 63 Ranexa R 63 Microspheres 63 Diabetic Macular Edema 63 Copegus R 63 Tacrolimus